APA (7th ed.) Citation

S, G., M, D., H, K., V, d. O., S, R., V, B., . . . M, B. (2022). Targeting hepatic kisspeptin receptor ameliorates nonalcoholic fatty liver disease in a mouse model. The Journal of clinical investigation, 132(10), . https://doi.org/10.1172/JCI145889

Chicago Style (17th ed.) Citation

S, Guzman, et al. "Targeting Hepatic Kisspeptin Receptor Ameliorates Nonalcoholic Fatty Liver Disease in a Mouse Model." The Journal of Clinical Investigation 132, no. 10 (2022). https://doi.org/10.1172/JCI145889.

MLA (9th ed.) Citation

S, Guzman, et al. "Targeting Hepatic Kisspeptin Receptor Ameliorates Nonalcoholic Fatty Liver Disease in a Mouse Model." The Journal of Clinical Investigation, vol. 132, no. 10, 2022, https://doi.org/10.1172/JCI145889.